Friday, September 21, 2012 8:18:44 AM
6:41 AM 9/20/2012 - StreetInsider
Barclays upgraded Cellcom Israel (NYSE: CEL) from Underweight to Equalweight.
For an analyst ratings summary and ratings history on Cellcom Israel click here. For more ratings news on Cellcom Israel click here.
Shares of Cellcom Israel closed at $8.31 yesterday, with a 52 week range of $4.98-$22.83.
Recent CEL News
- Celadon hails early results of chronic pain trial • Alliance News • 03/08/2024 08:04:45 PM
- Celadon Pharmaceuticals PLC Early Economic Analysis of Feasibility Study Data • RNS Non-Regulatory • 03/07/2024 07:00:13 AM
- Celadon announces start of cannabis supply for two UK companies • Alliance News • 12/14/2023 02:18:53 PM
- Celadon Pharmaceuticals PLC Product Supplied to First Two Sales Contracts • UK Regulatory • 12/14/2023 07:00:00 AM
- Celadon Pharma raises GBP2.0 million via placing • Alliance News • 12/12/2023 05:40:04 PM
- Celadon Pharmaceuticals PLC Fundraise, Update on Future CLN Financing & TVR • UK Regulatory • 12/12/2023 02:00:00 PM
- Celadon shares rise on supply contract worth up to GBP26 million • Alliance News • 11/16/2023 11:45:35 AM
- Celadon Pharmaceuticals PLC New European Sales Contract • UK Regulatory • 11/16/2023 07:00:00 AM
- Celadon Pharmaceuticals raises GBP1.0 million through shares • Alliance News • 10/13/2023 02:42:26 PM
- Celadon Pharmaceuticals PLC Fundraise, CLN Issue, Joint Broker Appointed & TVR • UK Regulatory • 10/13/2023 06:00:00 AM
- Celadon Pharmaceuticals interim loss narrows; optimistic for future • Alliance News • 09/28/2023 11:14:47 AM
- Celadon Pharmaceuticals PLC Interim Results • UK Regulatory • 09/28/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC Notice of Results and Investor Presentation • UK Regulatory • 09/18/2023 06:00:00 AM
- Celadon shares rise on second UK contract win for cannabis product • Alliance News • 09/05/2023 09:48:42 AM
- Celadon Pharmaceuticals PLC New Sales Contract with UK Pharmaceutical Company • UK Regulatory • 09/05/2023 06:00:00 AM
- Celadon receives approval for 5,000 patient clinical cannabis trial • Alliance News • 08/01/2023 10:44:46 AM
- Celadon Pharmaceuticals PLC Approval to roll-out chronic pain clinical trial • UK Regulatory • 08/01/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC Result of AGM • UK Regulatory • 06/29/2023 04:30:00 PM
- Celadon Pharmaceuticals PLC Publication of Annual Report and Notice of AGM • UK Regulatory • 06/05/2023 01:46:00 PM
- Celadon Pharmaceuticals loss widens; confident amid three-year deal • Alliance News • 06/05/2023 11:23:05 AM
- Celadon Pharmaceuticals PLC Final Results for the year ended 31 December 2022 • UK Regulatory • 06/05/2023 06:00:00 AM
- Celadon secures GBP7 million credit facility as product demand grows • Alliance News • 05/30/2023 10:56:00 AM
- Celadon Pharmaceuticals PLC GBP7 Million Committed Credit Facility • UK Regulatory • 05/30/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC Notice of Results and Investor Presentation • UK Regulatory • 05/26/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC West Midlands Mayor Visits Celadon's Facility • RNS Non-Regulatory • 05/25/2023 06:00:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM